HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Consumer Health Market Oversight Stays In Spotlight In Gottlieb's Final Week

Executive Summary

In four days before Scott Gottlieb's stint as commissioner ended, FDA announced official start of initiative to consider regulatory pathways to make CBD compliant as a dietary ingredient, launched another shot across kratom sector's bow and noted more examples of e-cigarette marketers crossing regulatory lines.

Advertisement

Related Content

Nicotine Poisoning Seizures Darken Cloud Around E-Cigarettes' NRT Potential
FDA Opens CBD Regulatory Path Docket, Warns Firms On Claims Missteps
Wider Options In FDA's NRT Clinical Trial Guidance, Approval Path Still Narrow
Wellness Industry News: Acting FDA Commissioner Named, Thorne Test Line Grows, Nitrosigine In Revel Energy, More
US International Mail Shipment Searches Reap More Spiked Supplements
US House Committee Requests Proof Of FDA Progress Seizing Opioids In International Mail
Smoking Cessation Indication For E-Cigarettes Could Fade Under Cloud Of Nicotine Packaged For Children
Ion Spectrometer Improves FDA's Import Screening: Health And Wellness Industry News
Kratom Advocates Urge Industry Compliance, FDA And DEA Compassion
DEA Takes Comments On Kratom, But Keeps Eye On Scheduling

Topics

Advertisement
UsernamePublicRestriction

Register

RS148697

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel